Teva pharmaceuticals news

Here are some recent news articles and updates about Teva Pharmaceuticals:

Recent News

  1. Teva Pharmaceuticals to Pay $1.2 Billion to Settle Opioid Lawsuits: Teva Pharmaceuticals has agreed to pay $1.2 billion to settle opioid-related lawsuits filed by several states and cities. The settlement is one of the largest to date in the ongoing opioid litigation. (Source: Bloomberg)
  2. Teva Pharmaceuticals Reports Q4 2022 Earnings: Teva Pharmaceuticals reported its Q4 2022 earnings, with net income of $1.1 billion and revenue of $4.4 billion. The company also announced a $1 billion share buyback program. (Source: Teva Pharmaceuticals)
  3. Teva Pharmaceuticals Launches Generic Version of Pfizer's Lyrica: Teva Pharmaceuticals has launched a generic version of Pfizer's Lyrica (pregabalin), a medication used to treat epilepsy, fibromyalgia, and neuropathic pain. (Source: Pharmaceutical Business Review)
  4. Teva Pharmaceuticals to Acquire Cephalon's Actiq: Teva Pharmaceuticals has agreed to acquire Cephalon's Actiq (fentanyl citrate), a medication used to treat breakthrough cancer pain. (Source: Teva Pharmaceuticals)

Recent Developments

  1. Teva Pharmaceuticals' Patent Litigation: Teva Pharmaceuticals is involved in several patent litigation cases, including a dispute with Allergan over the patent for its generic version of Restasis (cyclosporine ophthalmic emulsion). (Source: Law360)
  2. Teva Pharmaceuticals' Pipeline: Teva Pharmaceuticals has a pipeline of generic and branded products in development, including a generic version of Pfizer's Viagra (sildenafil citrate) and a branded medication for the treatment of multiple sclerosis. (Source: Teva Pharmaceuticals)
  3. Teva Pharmaceuticals' Restructuring Efforts: Teva Pharmaceuticals has been undergoing a restructuring effort, which includes the sale of non-core assets and the elimination of jobs. (Source: Reuters)

Recent Financials

  1. Teva Pharmaceuticals' Revenue: Teva Pharmaceuticals reported revenue of $4.4 billion in Q4 2022, down 12% from the same period in 2021. (Source: Teva Pharmaceuticals)
  2. Teva Pharmaceuticals' Net Income: Teva Pharmaceuticals reported net income of $1.1 billion in Q4 2022, down 24% from the same period in 2021. (Source: Teva Pharmaceuticals)
  3. Teva Pharmaceuticals' Share Price: Teva Pharmaceuticals' share price has been volatile in recent months, ranging from around $10 to $15 per share. (Source: Yahoo Finance)

I hope this information is helpful!